Vanguard Advisers’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-4
Closed -$1.45K – 773
2026
Q2
$1.45K Sell
4
-8
-67% -$2.74K ﹤0.01% 565
2026
Q1
$4.22K Buy
+12
New +$4.28K ﹤0.01% 452

Other funds holding AMGN

Vanguard Advisers's AMGN Position: Q3 2026 in Review

Vanguard Advisers sold out of Amgen (AMGN) in Q3 2026, closing a stake of 4 shares — an estimated $1.45K sold.

Vanguard Advisers first reported a position in AMGN in Q1 2026 and held it in 2 quarters. The position peaked at $4.22K in Q1 2026. 3,227 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Vanguard Advisers reported no remaining Amgen position as of Q3 2026 after selling out during the quarter.
  • Vanguard Advisers sold 4 Amgen shares in Q3 2026, an estimated $1.45K.
  • Vanguard Advisers first reported a position in Amgen in Q1 2026 and held it in 2 quarters.
  • Vanguard Advisers's Amgen position peaked at $4.22K in Q1 2026.
  • 3,227 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Vanguard Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.